Harnessing Dendritic Cells for Poly (D,L-lactide-co-glycolide) Microspheres (PLGA MS) : Mediated Anti-tumor Therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Frontiers in Immunology ; 10 (2019). - 707. - eISSN 1664-3224
- Event
-
Veröffentlichung
- (where)
-
Konstanz
- (who)
-
KOPS Universität Konstanz
- (when)
-
2019
- Creator
- URN
-
urn:nbn:de:bsz:352-2-nhh6lhe727a29
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:48 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Koerner, Julia
- Horvath, Dennis
- Groettrup, Marcus
- KOPS Universität Konstanz
Time of origin
- 2019
Other Objects (12)
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Tumor eradication by immunotherapy with biodegradable PLGA microspheres : an alternative to incomplete Freund's adjuvant
Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP mice
Cytotoxic T cell vaccination with PLGA microspheres interferes with influenza A virus replication in the lung and suppresses the infectious disease
PLGA particle vaccination elicits resident memory CD8 T cells protecting from tumors and infection
Editorial Overview: Molecular immunology : targeting the immune system
Subunit specific inhibitors of proteasomes and their potential for immunomodulation
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
The unique functions of tissue-specific proteasomes
No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes
Advances in Prostate Cancer Immunotherapies
The ubiquitin-like modifier FAT10 in cancer development
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Tumor eradication by immunotherapy with biodegradable PLGA microspheres : an alternative to incomplete Freund's adjuvant
Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP mice
Cytotoxic T cell vaccination with PLGA microspheres interferes with influenza A virus replication in the lung and suppresses the infectious disease
PLGA particle vaccination elicits resident memory CD8 T cells protecting from tumors and infection
Editorial Overview: Molecular immunology : targeting the immune system
Subunit specific inhibitors of proteasomes and their potential for immunomodulation
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
The unique functions of tissue-specific proteasomes
No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes
Advances in Prostate Cancer Immunotherapies
The ubiquitin-like modifier FAT10 in cancer development
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Tumor eradication by immunotherapy with biodegradable PLGA microspheres : an alternative to incomplete Freund's adjuvant
Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP mice
Cytotoxic T cell vaccination with PLGA microspheres interferes with influenza A virus replication in the lung and suppresses the infectious disease
PLGA particle vaccination elicits resident memory CD8 T cells protecting from tumors and infection
Editorial Overview: Molecular immunology : targeting the immune system
Subunit specific inhibitors of proteasomes and their potential for immunomodulation
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
The unique functions of tissue-specific proteasomes
No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes
Advances in Prostate Cancer Immunotherapies